Last $126.71 USD
Change Today -1.56 / -1.22%
Volume 588.1K
IDXX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

idexx laboratories inc (IDXX) Snapshot

Open
$129.15
Previous Close
$128.27
Day High
$129.99
Day Low
$125.58
52 Week High
07/25/14 - $140.00
52 Week Low
09/3/13 - $92.09
Market Cap
6.4B
Average Volume 10 Days
541.8K
EPS TTM
$3.67
Shares Outstanding
50.3M
EX-Date
--
P/E TM
34.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for IDEXX LABORATORIES INC (IDXX)

idexx laboratories inc (IDXX) Related Bloomberg News

View More Bloomberg News

idexx laboratories inc (IDXX) Related Businessweek News

No Related Businessweek News Found

idexx laboratories inc (IDXX) Details

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. The company operates through Companion Animal Group, Water, Livestock and Poultry Diagnostics, Dairy, and OPTI Medical segments. The company primary offers point-of-care veterinary diagnostic products comprising instruments and consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; and practice management systems and services, and digital radiography systems used by veterinarians. It also provides biological materials testing and laboratory diagnostic instruments and services used by the biomedical research community; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; products that test milk for antibiotic residues and other contaminants; and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market. The company markets and sells its products through marketing, sales, and technical service groups, as well as independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

5,700 Employees
Last Reported Date: 02/18/14
Founded in 1983

idexx laboratories inc (IDXX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $784.6K
Executive Vice President
Total Annual Compensation: $396.2K
Executive Vice President
Total Annual Compensation: $396.2K
Executive Vice President
Total Annual Compensation: $396.2K
Vice President of Finance
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2013.

idexx laboratories inc (IDXX) Key Developments

Idexx Laboratories, Inc. Issues $125 Million Senior Notes

On July 21, 2014, IDEXX Laboratories, Inc. issued and sold to accredited institutional investors through a private placement an aggregate principal amount of $125 million of its senior notes consisting of $50 million of seven-year notes at an interest rate of 3.32% and $75 million of ten-year notes at an interest rate of 3.76%. On July 22, 2014, the company also executed an agreement for a private placement of an additional $75 million of its twelve-year senior notes at an interest rate of 3.72% with funding anticipated to occur in September 2014. The proceeds from the offerings will be used to reduce outstanding amounts under the recently expanded $700 million revolving credit facility.

IDEXX Laboratories, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Year 2014

IDEXX Laboratories, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue of $390,122,000 compared to $352,583,000 a year ago. Income from operations was $83,219,000 compared to $78,763,000 a year ago. Income before provision for income taxes was $80,742,000 compared to $78,028,000 a year ago. Net income attributable to stockholders was $57,218,000 or $1.10 per diluted share compared to $53,995,000 or $0.99 per diluted share a year ago. For the six months, the company reported revenue of $750,325,000 compared to $684,688,000 a year ago. Income from operations was $153,265,000 compared to $139,949,000 a year ago. Income before provision for income taxes was $148,485,000 compared to $138,824,000 a year ago. Net income attributable to stockholders was $103,803,000 or $1.99 per diluted share compared to $98,854,000 or $1.80 per diluted share a year ago. Net cash provided by operating activities was $115,280,000 compared to $102,484,000 a year ago. Purchases of property and equipment were $25,410,000 compared to $46,181,000 a year ago. Acquisition of intangible assets was $175,000 compared to $659,000 a year ago. The company provided earnings guidance for the year 2014. For the year, the company expects revenue to be in the range of $1,510 million to $1,520 million, Adjusted EPS to be in the range of $3.79 to $3.86, free cash flow to be 95% to 100% of net income and capital expenditure to be $80 million. Reported revenue growth for 2014 is projected at 10.0% to 10.5%. The company expects EPS to be in the range of $3.54 to $3.63.

IDEXX Laboratories, Inc. to Report Q2, 2014 Results on Jul 25, 2014

IDEXX Laboratories, Inc. announced that they will report Q2, 2014 results at 7:00 AM, US Eastern Standard Time on Jul 25, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDXX:US $126.71 USD -1.56

IDXX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $47.44 USD +0.23
Hologic Inc $25.96 USD +0.43
MEDNAX Inc $60.00 USD +1.59
ResMed Inc $51.80 USD +0.40
Siemens Ltd 884.75 INR -13.60
View Industry Companies
 

Industry Analysis

IDXX

Industry Average

Valuation IDXX Industry Range
Price/Earnings 35.0x
Price/Sales 4.5x
Price/Book 14.3x
Price/Cash Flow 33.5x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDEXX LABORATORIES INC, please visit www.idexx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.